HomeMedicines from India › Revolade (Eltrombopag) 25 mg, 14 tablets

Revolade (Eltrombopag) 25 mg, 14 tablets: profile, composition and research

Reference page for Revolade (Eltrombopag) 25 mg, 14 tablets. Active substance: Элтромбопаг / Eltrombopag.

In short

Key facts

Active substanceEltrombopag
FormTablets
Strength25 mg per tablet
Pack size14 tablets
CategoryPrescription medicine
Article (SKU)00017
Revolade (Eltrombopag) 25 mg, 14 tablets
Price, availability and delivery terms: on the pharmacy site
View at APV Pharmacy

What eltrombopag is

Revolade is a medicine whose active substance is eltrombopag. It is a small synthetic molecule rather than a protein, and it is taken by mouth. By its mechanism it belongs to the class of thrombopoietin receptor agonists.

Platelets are the cells that stop bleeding. When their number falls below a safe level the condition is called thrombocytopenia, and even a minor injury to a vessel becomes significant. Eltrombopag helps the bone marrow produce more of these cells.

The medicine comes as 25 mg tablets. A pack holds 14 tablets.

How eltrombopag works

The natural hormone

Platelet production is regulated by thrombopoietin. This hormone is made mainly in the liver and binds to a receptor on the surface of megakaryocytes, the large bone-marrow cells that later break up into thousands of platelets.

An unusual binding site

Eltrombopag attaches to a different part of the same receptor, not the site used by the natural hormone. As a result it does not displace thrombopoietin, and the two signals add up.

The signal inside the cell

Receptor activation switches on the JAK/STAT and MAPK cascades. Progenitor cells divide and mature more actively, and the number of fully functional platelets rises.

Approved uses

The manufacturer's information lists chronic immune thrombocytopenia in adults, severe aplastic anaemia and thrombocytopenia associated with chronic hepatitis C. In some situations the medicine is considered after earlier options have failed.

It is a prescription medicine. A haematologist decides on it from examination results, not a reference page. Using it on one's own is not acceptable.

Monitoring during treatment

Eltrombopag affects blood formation, so treatment is accompanied by regular tests. The doctor assesses platelet counts and other blood parameters and builds the approach on them.

Among the cautions noted by the manufacturer are an increased risk of thrombosis, liver changes and bone-marrow effects. Any new complaint should be reported to a doctor.

Published research

Primary sources, verified against PubMed:

Listed for reference. Publication of a study is not a claim about this particular product.

Precautions

Frequently asked

Is Revolade a prescription medicine?

Yes. It is a prescription medicine and is not intended for self-medication.

Why does this page not give a dosing schedule?

The regimen depends on the diagnosis, blood counts and tolerability. That is a physician's decision, not a reference page's.

Are tests needed during treatment?

Yes, blood monitoring is obligatory. The doctor sets how often checks are done.

Where does the order ship from?

Shipping and customs handling are described on the APV Pharmacy delivery page.

Important. This page is reference material and is not medical advice or instruction for use. The product is prescription-only: medical supervision and laboratory monitoring are required. Always consult a qualified healthcare professional.